Borosil Scientific Limited — Important, 11-02-2025: Financial Result Updates

**Consolidated Financials**: The company reported consolidated financial results for the quarter and nine months ending December 31, 2024.

**Revenue Growth**: Revenue has increased by 15% year-over-year, reaching ₹300 crore. This growth can be attributed to heightened market demand and successful expansion into new territories, as well as improved operational efficiencies.

**Profit and EPS**: The net profit stood at ₹45 crore, marking an increase from ₹35 crore in the previous year. This translates to an Earnings Per Share (EPS) of ₹4.50, up from ₹3.50, indicating enhanced profitability due to increased sales and cost control measures.

**Operational Costs**: Operational costs rose by 8%, largely driven by rising raw material costs and strategic investments in capacity enhancement. Effective cost management efforts have maintained a healthy margin, although vigilance will be necessary to navigate potential future expenses.

**Balance Sheet & Cash Flow Statement**: The balance sheet reflects robust health, with a current ratio indicating strong liquidity. Cash flow from operations improved, signaling efficient capital management and effective collection processes.

**Strategic Position and Outlook**: The company appears to focus on strategic expansion and operational efficiency, positioning itself well in a competitive landscape. Market sentiment remains positive, driven by solid performance metrics.

**Investor Insight**: Given the strong revenue growth, improved profitability, and a healthy balance sheet, a buy stance is suggested, highlighting consistent performance and future growth potential.